HPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Heidelberg Pharma AG

Watchlist Manager

Watchlist

Price: 2.67 EUR -0.74% Market Closed

Market Cap: €124.9m

	Heidelberg Pharma AG XETRA:HPHA	DE
P	Panasonic Holdings Corp DUS:MAT1	JP
W	Wartsila Oyj Abp OMXH:WRT1V	FI
	Pernod Ricard SA F:PER0	FR
I	Itochu Corp OTC:ITOCF	JP
	Fidus Investment Corp NASDAQ:FDUS	US
	Kering SA PAR:KER	FR

Profitability Summary

Heidelberg Pharma AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

77%

Gross Margin is Increasing

72% > 81%

Negative Operating Margin

-3.145%

Negative 3Y Average Operating Margin

-600%

Declining Operating Margin

-84% > -3.145%

Negative Net Margin

-2.901%

Negative 3Y Average Net Margin

-560%

Declining Net Margin

-96% > -2.901%

Negative Free Cash Flow Margin

-2.178%

Negative 3Y Average Free Cash Flow Margin

-623%

Declining Free Cash Flow Margin

-70% > -2.178%

Negative ROE

-424%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-120%

Declining ROIC

-108% > -225%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.